Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
2917
|
Gene name
Gene Name - the full gene name approved by the HGNC.
|
Glutamate metabotropic receptor 7 |
Gene symbol
Gene Symbol - the official gene symbol approved by the HGNC.
|
GRM7 |
Synonyms (NCBI Gene)
Gene synonyms aliases
|
GLUR7, GPRC1G, MGLU7, MGLUR7, NEDSHBA, PPP1R87 |
Disease Acronyms (UniProt)
Disease acronyms from UniProt database
|
NEDSHBA |
Chromosome
Chromosome number
|
3 |
Chromosome location
Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
3p26.1 |
Summary
Summary of gene provided in NCBI Entrez Gene.
|
L-glutamate is the major excitatory neurotransmitter in the central nervous system, and it activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be pert |
Causal |
Disease term |
Disease name |
dbSNP ID |
References |
Attention deficit hyperactivity disorder |
Attention Deficit Disorder, Attention deficit hyperactivity disorder |
rs786205019 |
22138692 |
Developmental delay |
Global developmental delay |
rs28941770, rs199469464, rs281865469, rs143747297, rs398123009, rs587777428, rs786205133, rs606231459, rs797044854, rs797045027, rs864309504, rs878853160, rs886039902, rs886042046, rs886041291, rs886041382, rs1057518991, rs1057518699, rs753254213, rs748294403, rs762552974, rs1135401795, rs1553121073, rs1553122926, rs1364690005, rs1554086554, rs1554210415, rs1554168326, rs1554776342, rs1553873247, rs1567860112, rs779009256, rs1557447255, rs1564568350, rs780011005, rs1597464953, rs1200336864, rs1569513017, rs1587459606, rs1570332505, rs748888652, rs1575155995, rs2087029320, rs1589669105, rs1601769604, rs1184981709, rs749201074 View all (32 more) |
|
Prostate cancer |
Malignant neoplasm of prostate |
rs121909139, rs121909140, rs121909141, rs121909142, rs121909143, rs606231169, rs606231170, rs137852584, rs137852578, rs137852580, rs137852581, rs137852582 |
24185611 |
Schizophrenia |
Schizophrenia |
rs13447324, rs387906932, rs387906933, rs863223354, rs863223355, rs776061422, rs863223349, rs748809996, rs759748655, rs863223353, rs863223350, rs863223356, rs781821239, rs863223348, rs863223346, rs863223347, rs863223351, rs863223352, rs61734270, rs797045205, rs869312829, rs869312830, rs770913157, rs869312832, rs869312831, rs781720548, rs1262969313 View all (12 more) |
19638256, 19351574, 26254163, 18329248 |
|
Unknown |
Disease term |
Disease name |
Evidence |
References |
Source |
Mental depression |
Mental Depression, Depressive disorder, Unipolar Depression, Major Depressive Disorder |
|
20038947, 22287544, 23059104, 20423346, 24596089, 20398908, 21813496, 20638442, 24278217 |
ClinVar |
Panic Disorder |
Panic Disorder |
|
|
GWAS |
Colorectal Cancer |
Colorectal Cancer |
In summary, our data strongly demonstrated that upregulation of GRB7 conferred MEKi resistance in CRC cells with KRAS mutations by mediating RTK signaling through the recruitment of PLK1. |
|
GWAS, CBGDA |
Oligodendroglioma |
Oligodendroglioma |
|
|
GWAS |
Leprosy |
Leprosy |
|
|
GWAS |
Insomnia |
Insomnia |
|
|
GWAS |
|
Associations from Text Mining |
Disease Name |
Relationship Type |
References |
Acute Kidney Injury |
Associate
|
26083657 |
Age Related Hearing Impairment 1 |
Associate
|
20068591, 24146964, 29455378, 30100543 |
Alzheimer Disease |
Associate
|
32694537 |
Anxiety |
Associate
|
21368711 |
Anxiety Disorders |
Associate
|
23295062 |
Atrophy |
Associate
|
32286009, 34273994 |
Attention Deficit Disorder with Hyperactivity |
Associate
|
22138692, 23295062, 37964012 |
Autism Spectrum Disorder |
Associate
|
31707215 |
Bipolar Disorder |
Associate
|
24804643, 27063557 |
Breast Neoplasms |
Associate
|
21688152 |
Corneal Dystrophy Band Shaped |
Associate
|
24146964 |
COVID 19 |
Associate
|
34204705 |
Demyelinating Diseases |
Associate
|
32286009 |
Developmental Disabilities |
Associate
|
32286009 |
Epilepsy |
Associate
|
32286009 |
Epilepsy Benign Neonatal |
Associate
|
32286009 |
Epileptic Encephalopathy Early Infantile 3 |
Associate
|
32286009, 34273994 |
Glioblastoma |
Associate
|
39643066 |
Glioma |
Associate
|
39643066 |
Hashimoto Disease |
Associate
|
34493981 |
Head and Neck Neoplasms |
Associate
|
36010616 |
Hearing Loss |
Associate
|
23102807, 30528655 |
Hearing Loss Noise Induced |
Associate
|
29301492 |
Hearing Loss Sensorineural |
Associate
|
30528655 |
Hyperkinesis |
Associate
|
31707215 |
Hypertension |
Associate
|
26866891 |
Intellectual Disability |
Associate
|
34273994 |
Microcephaly |
Associate
|
32286009, 34273994 |
Obesity |
Associate
|
28489853 |
Osteoporosis |
Associate
|
23102807, 29301492 |
Presbycusis |
Associate
|
23102807 |
Prostatic Neoplasms |
Associate
|
37279148 |
Schizophrenia |
Associate
|
28750581 |
Substance Related Disorders |
Associate
|
27788777 |
Tobacco Use Disorder |
Associate
|
27711239 |
Triple Negative Breast Neoplasms |
Associate
|
21152100 |
Uniparental Disomy |
Associate
|
21152100 |
|